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OBJECTIVES: The aim of this cross-sectional study was to evaluate whether interleukin 10 (IL10) and
transforming growth factor b1 (TGFb1) gene polymorphisms were associated with persistent IgE-mediated
cow’s milk allergy in 50 Brazilian children. The diagnostic criteria were anaphylaxis triggered by cow’s milk or a
positive double-blind, placebo-controlled food challenge. Tolerance was defined as the absence of a clinical
response to a double-blind, placebo-controlled food challenge or cow’s milk exposure.
METHOD: The genomic DNA of the 50 patients and 224 healthy controls (HCs) was used to investigate five
IL10 gene polymorphisms (-3575A/T, -2849A/G, -2763A/C, -1082G/A, -592C/A) and one TGFb1 polymorphism
(-509C/T).
RESULTS: Among the five IL10 polymorphisms analyzed, homozygosis for the G allele at the -1082 position
was significantly higher in the patients compared with the healthy controls (p = 0.027) and in the persistent
cow’s milk allergy group compared with the healthy controls (p = 0.001).
CONCLUSIONS: Homozygosis for the G allele at the IL10 -1082G/A polymorphism is associated with the
persistent form of cow’s milk allergy.
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& INTRODUCTION
The prevalence of food allergy has been increasing over
the last decades. Many reports indicate that new eating
habits associated with epigenetic factors may be responsible
for this change worldwide (1,2).
Sensitization, the first step in food allergy, is characterized
by allergen-specific IgE production along with a Th2
immune response, inflammatory cytokine release and the
onset of signs and symptoms (3). Despite the daily ingestion
of many proteins in the diet, only a few are associated with
clinical manifestations of allergy: cow’s milk (CM), soy,
eggs, peanuts, wheat, nuts, fish and crustaceans (4,5). CM
allergy (CMA) is one of the leading causes of food allergy in
childhood, affecting 2.5% of children under the age of 3 and
6% of children under the age of 4 (4). CM proteins, such as
casein, beta-lactoglobulin and alpha-lactalbumin, may be
involved in long-term immunological learning (6). Although
most patients overcome the allergy, the persistence of CMA
has been reported (7). CMA prognosis is usually good in
patients developing tolerance up to 3 years of age, although
recent studies have shown more severe outcomes in patients
with IgE-mediated CMA (5). The persistence of CMA has
also been associated with sensitization to casein and the
occurrence of anaphylaxis (6).
Predictive markers of persistent CMA have been exten-
sively studied to identify groups eligible for new treatments
targeted to induce tolerance, such as immunotherapy with
food allergens associated with bacterial products or the use
of genetically modified allergens. A number of regulatory
cells play a key role in the immune response to food,
including (CD4+CD25+) lymphocytes (Treg), Th3 cells and T
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regulatory type 1 cells (Tr1), which produce immunoregu-
latory cytokines, such as transforming growth factor b1
(TGFb1) and interleukin 10 (IL10). A reduction in TGFb1
production due to the inadequate stimulation of innate
immunity by intestinal microflora may contribute to the
failure of oral tolerance (8). Several studies have associated
low TGFb1 levels with sensitization to food (8,9). The
deletion/anergy of reactive T cells against specific antigens
associated with the expanding population of regulatory T
cells and the production of IL10 are mechanisms involved in
oral tolerance (3).
The present study aimed to investigate whether the
presence of single nucleotide polymorphisms (SNPs) in
such immunoregulatory genes as IL10 and TGFb1 are
associated with demographic and clinical data in order to
better characterize the group of children at a high risk of
evolving persistent CMA.
& MATERIALS AND METHODS
Ethics statement
Written informed consent was obtained from all partici-
pants, and the study was approved by the Internal Review
Board of the University of Sa˜o Paulo (CAPpesq n 1˚107/07,
03/17/2008). Permission to use DNA samples from HCs
was also granted strictly according to the Brazilian Ethical
Committee guidelines (CAPpesq n 5˚60/00, 08/09/2002).
Study population
This study enrolled 50 children older than 5 years of age
with IgE-mediated CMA who were followed up at the Child
Institute, General Hospital, Faculdade de Medicina da
Universidade de Sa˜o Paulo, Brazil. The children were
diagnosed according to the following criteria: anaphylaxis
triggered by CM or immediate clinical reactivity induced by
CM during a double-blind, placebo-controlled food chal-
lenge (DBPCFC). The patient group was compared with 224
HCs recruited from bone marrow donors at the same
hospital. These individuals were clinically evaluated to
exclude any type of allergy.
DNA preparation
Blood samples were obtained from the CMA patients.
Genomic DNA was extracted according to the DTAB/CTAB
method (10).
SNP selection and genotyping
The choice of SNPs was made on the basis of the SNPs’
role in cytokine production (11-13).
SNPs located at the promoter region of the IL10 gene or at
the -3575 (rs1800890), -2849 (rs6703630), -2763 (rs6693899) or
-592 (rs1800872) position were tested by polymerase chain
reaction (PCR)-RFLP according to previously described
protocols (14,15).
Briefly, PCR was performed in a final volume of 25 mL
containing 100 ng of genomic DNA, 40 mM dNTP, 0.2 U of
Taq polymerase, 1.5 mM MgCl2 and 0.25 pM of each
primer. In the case of the -592 SNP, 2.0 mM MgCl2 and
0.5 pM of each primer was used. The PCR conditions were
an initial denaturation step at 95 C˚ for 5 min, followed by 35
cycles at 95 C˚ for 20 s; annealing temperatures of 62 C˚
(-3575), 60 C˚ (-2849 and -2763) or 56 C˚ (-592) for 30 s; and an
extension step at 72 C˚ for 20 s, ending with 7 min at 72 C˚.
An aliquot of 10 mL of the PCR product was digested for 3 h
at 37 C˚ with 2.5 U of Apo I (-3575), 2.5 U of Alw I (-2849),
5 U of Dde I (-2763) or 3.0 U of Rsa I (all enzymes from New
England Biolabs, Ipswich, MA) in a total volume of 20 mL.
Digestion products were separated by electrophoresis in 4%
agarose gels, stained with ethidium bromide and visualized
under UV light.
The IL10 -1082 polymorphism (rs1800896) was genotyped
using an allele-specific PCR (ASPCR). The specific primer S1
or S2 paired with the common primer C were used to
amplify a 258 bp fragment (16). The housekeeping hGH
gene was used as an internal control, yielding a 480 bp
amplification product. PCR was performed using the same
conditions as for the IL10 -592 polymorphism.
The TGFb1 -509 polymorphism (rs1800469) was typed by
PCR-RFLP with primers described elsewhere (17). Briefly,
PCR-RFLP was performed in a final volume of 25 mL
containing 100 ng of genomic DNA, 40 mM dNTP, 0.2 U of
Taq polymerase, 1.5 mM MgCl2 and 0.25 pM of each
primer, using the same protocol as for IL10 -592. An aliquot
of 20 mL of the PCR product was digested for 3 h at 37 C˚
with 3 U of Dde I (New England Biolabs) in a total volume
of 40 mL. Digestion products were separated by electro-
phoresis in a 4% agarose gel, stained with ethidium bromide
and visualized under UV light.
Statistics
Considering a type I error to be 0.05 and a relative risk of
2.5, defined according to our significant results, the power
was estimated to detect statistically significant differences
for the SNP frequencies in the two studied groups (CMA
and HC) EPI Center version 4.1 (Extreme Networks, Inc.,
Santa Clara, California, USA). The values obtained were
76% and 67% for IL10 -1082 G/A and TGFb1 -509C/T,
respectively, and 66% for IL10 -1082 G/A considering the
CMA group (persistent, n = 36), indicating that our sample
size was adequate to avoid false-negative association.
Genotype and allele frequencies were calculated by direct
gene counting. Comparisons between the CMA and HC
groups were performed by the 2 test along with calculation
of the odds ratio (OR) and 95% confidence interval (CI).
Statistical comparisons were performed using Fisher’s exact
test whenever a value in the contingency table was below
five and to perform genotype analysis using GraphPad
Prism version 5.0 software. The p values were corrected for
the number of different alleles tested (pc). Statistical
significance was defined as a p value less than 0.05.
Haplotype frequency, Hardy-Weinberg expectation (HWE)
and linkage disequilibrium (LD) analyses were performed
using Arlequin 3.1 software (18).
A logistic regression model was applied, considering the
development of tolerance as a dichotomous variable, and
continuous and qualitative parameters in univariate analy-
sis were considered to be independent variables. Parameters
with p,0.2 (sex, anaphylaxis, the presence of other allergic
diseases, IgE serum levels and specific IgE) were initially
included in the multivariable analysis, and only those
parameters with p,0.05 were considered to be significant.
These analyses were performed considering genotypes and
allele carriage (the number of individuals having the allele
on either one or both chromosomes). IgE levels (BN100;
Siemens Healthcare Diagnostics, Marburg, Germany) were
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categorized into two groups: normal and elevated, accord-
ing to the reference interval defined for each age by the
manufacturer.
& RESULTS
Clinical features of and laboratory findings for the
children with CMA
The 50 studied patients were divided into two groups
according to their clinical evolution: 36 patients were
classified with persistent CMA (group P) and 14 were
classified with tolerant CMA (group T). The onset of disease
occurred very early in both groups, with no difference in the
median age, although signs and symptoms appeared later in
the persistent CMA group (15 vs 2 days). Familial atopy was
slightly more frequent in the persistent CMA group
compared with the tolerant CMA group (72% vs 57%).
Anaphylaxis was associated with the persistent CMA group
(p= 0.004). Similar trends were observed regarding the
presence of wheezing (p= 0.018) and other allergies, such
as asthma, rhinitis or dermatitis (p= 0.031) (Table 1).
Association of TGFb1 and IL10 gene polymorphisms
with CMA
All six genotyped SNPs are in HWE. The five IL10
polymorphisms were in strong LD (data not shown). We
observed a statistically significant difference in both the
allele and the genotype distributions of the IL10 -1082 G/A
polymorphism when CMA patients were compared with
HCs. Homozygosis for the G allele was higher in the CMA
group compared with the HC group (19 vs 12%; p= 0.027),
but this difference was not maintained after Bonferroni
correction (pc = 0.054) or in patients with persistent CMA
compared with HCs (24 vs 12%; p= 0.001; pc = 0.002). The
genotype containing the G allele (AG plus GG vs AA) was
significantly more frequent in the persistent CMA group
compared with the tolerant CMA group (OR = 6.77, 95% CI
1.59-28.73, p= 0.006). The presence of the G allele conferred a
twofold risk of developing persistent CMA (OR = 2.43, 95%
CI 1.45-4.08, p,0.001), and the risk was even higher in the
persistent CMA group compared with the tolerant CMA
group (OR = 3.24, 95% CI 1.20-8.76, p= 0.017) (Table 2).
The presence of the CC genotype in the TGFb1 -509C/T
promoter region showed an initial association with persis-
tent allergy compared with the genotype in tolerant patients
(14% vs 42%; p= 0.048) that was not maintained after
correction (pc = 0.096).
The remaining studied polymorphisms (IL10 -3575, IL10 -
2849, IL10 -2763 and IL10 -592) showed no association with
CMA (Supplementary Table 1).
Due the LD observed at the studied IL10 polymorphisms
(Figure 1), we analyzed the haplotypes containing these
SNPs, except for -892, which was excluded from this study
due to a strong association with -592 (r2 = 0.99). Three
different SNP combinations showed an association with
CMA. Curiously, the IL10 -3575A, IL10 -2849A, IL10 -2763C,
IL10 -1082G and IL10 -592C haplotypes, strongly associated
with CMA compared with HCs (p,0.001; OR = 4.71, 95% CI,
1.86-11.9 (Table 3), were completely absent in the tolerant
CMA group (data not shown).
Association of polymorphisms with clinical features
Several demographic and clinical variables, such as sex,
anaphylaxis, the presence of other allergic diseases and total
and specific IgE serum levels were analyzed together with
the six SNPs studied, comparing tolerant with persistent
CMA patients by means of a logistic regression model. The
results confirmed that the G allele carriage (AG plus GG) at
the IL10 -1082A/G polymorphism and homozygosis for the
C allele at the TGFb1 -509 T/C polymorphism were
associated with persistent CMA (p= 0.019 and p= 0.047,
respectively).
& DISCUSSION
In this study, we analyzed the main clinical characteristics
of 50 children with CMA and investigated whether the IgE-
mediated persistent form could be at least partially related
to the presence of SNPs in the promoter region of the IL10
and TGFb1 genes, leading to the altered expression of these
inflammation markers, which are involved in the gastro-
intestinal immune response and the development of food
tolerance.
To our knowledge, this is the first Brazilian study of
children with CMA that has attempted to associate genetic
aspects with IgE-mediated persistent disease. TGFb1 has a
fundamental role in intestinal homeostasis and oral toler-
ance to low antigen doses. In the gastrointestinal tract, this
protein is secreted by lymphocytes, contributing to IgA
secretion. Yamagiwa et al. (2001) showed that TGFb1 may
also contribute to the expansion of Treg (8). Moreover, a
reduction in TGFb1 production by the intestinal mucosal
cells of children with food allergy has been described (9). A
TGFb1 gene polymorphism at the -509 position is associated
with low cytokine levels caused by the modification of the
Table 1 - Clinical and laboratory characteristics of patients
with persistent or tolerant, IgE-mediated cow’s milk
allergy.
Tolerant Persistent p-value
(n = 14) (n = 36)
Sex F/M 8/6 13/23 ns
Age of onset (days)
Median 135 120 ns
Range 2-330 15-600
Diagnosis (days)
Median 195 180 ns
Range 20-900 15-690
Follow-up (months)
Median 48 46 ns
Range 11-124 5-164
Family atopy 8 26 ns
Anaphylaxis 3 24 0.004
Manifestation
Cutaneous 13 34 ns
Gastrointestinal 8 24 ns
Respiratory 7 26 0.018
Wheezing 1 27
Other food allergies 3 12 ns
Other allergiesa 6 27 0.031
IgE (IU/mL)
Median 186.5 473 ns
Range 9.3-10,180 43-6,740
Specific IgE (.0.35/total) ns
CM 14/14 33/35 ns
Alpha 8/10 20/23 ns
Beta 9/11 21/23 ns
Casein 10/11 21/24 ns
ns = not significant; aasthma, rhinitis or dermatitis.
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Yin Yang 1 transcription factor consensus binding site when
the allele C is present. Our findings are consistent with
homozygosis of the C allele (low producer) being associated
with the persistent form of CMA, but this result must be
confirmed by further studies. Several studies have asso-
ciated reduced levels of TGFb1 sensitization with foods
(8,9). The mechanism of oral tolerance involves the deletion
or anergy of T cells reactive with specific antigens associated
with the expanding population of regulatory T cells
following the production of TGFb1 and IL10 (3).
One of IL10’s main roles is the induction of oral tolerance,
which has been evidenced by the association of IL10 levels
with oral tolerance (19). Children with CMA who develop
tolerance have a high regulatory T cell (CD4+ CD25+) count
and a reduced proliferative response to beta-lactoglobulin in
vitro compared with children with clinically active disease
(20). Negoro et al. found an association of the A allele at the
IL10 -627 position with the low expression of this cytokine,
IgE levels and the severity of food allergy (20). Different
studies have associated IL10 polymorphisms with asthma
phenotypes in children, atopic dermatitis, the number of
circulating eosinophils and IgE levels (21,22). Our data
showed the association of the G allele at the IL10 -1082A/G
position with CMA. The reactivity of T cells in children with
CMA is associated with IL10 production (23). Previous data
showed an association of the GG genotype with an
exacerbation of asthma in Costa Rican children exposed to
dust mite allergens (24). A recent study showed a functional
role for this polymorphism, as the presence of the A allele is
associated with susceptibility to and the outcome of sepsis
(13). George et al. demonstrated that the A allele at the IL10-
1082A/G position is associated with lower IL10 expression
(25). Conversely, Giordani et al. observed increased IL10
expression in the presence of the allele G at -1082 position
(26). A recent study shows that polymorphisms in the IL10
gene may modify its effect in asthmatics’ airways (27).
Corroborating findings were observed in an Egyptian study
(28), demonstrating the important role of IL10 in allergic
processes.
Different SNP combinations in the IL10 gene may impact
cytokine production (29) and thus the outcome of immuno-
logical diseases. In the present study, we observed an
association of IL10 haplotypes with CMA and with
the persistent form of the disease. However, the ethnic
heterogeneity of our population might be a bias due to the
observed difference in IL10 polymorphism between
Brazilian and African-derived populations (30). Increased
Table 2 - Genotype and allele frequency of IL10 -1082 A/G polymorphism in children with cow’s milk allergy and in
healthy controls (HCs).
lL10 -1082A/G T (n = 13) p-value (n = 34) Total (n = 47) HC (n = 217) p-value pc 2 OR 95% CI
Genotype
AA 7 (54) 5 (14) 12 (26) 100 (46)
AG 5 (38) 21 (62) 26 (55) 91 (42) 0.032 ns 6.90
GG 1 (8) 8 (24) 9 (19) 26 (12)
Genotype comparisons
AA vs GG
CMA vs HC 0.027 ns 4.90 2.89 1.10-7.58
T vs HC ns
P vs HC 0.001 0.002 10.67 6.15 1.86-20.39
P vs T ns
AG and GG vs AA
CMA vs HC 0.001 0.002 6.68 2.49 1.23-5.06
T vs HC ns
P vs HC ,0.001 ,0.001 11.89 4.96 1.85-13.29
P vs T 0.006 0.016 7.58 6.77 1.59-28.73
Allele
A 19 (73) 31 (46) 50 (53) 291 (67)
G 7(27) 37 (54) 44 (47) 143 (33)
Allele comparison A vs G
CMA vs HC 0.011 0.022 6.49 1.74 1.14-2.81
T vs HC ns
P vs HC ,0.001 ,0.001 11.77 2.43 1.45-4.08
P vs T 0.017 0.034 5.71 3.24 1.20-8.76
HC = healthy control; n = number of individuals; 2 = Chi-square; OR = odds ratio; ns = not significant.
Figure 1 - Linkage disequilibrium (LD) map of the IL10 SNPs
rs1800872, 1800896, 6693899, 3703630 and 1800890. An LD map
based on the controls was drawn using Haploview version 4.1.
Triangular heat map display of the LD index. Pairs of the IL10 SNP
alleles in strong LD (D9.0.75) are highlighted in gray or black.
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expression levels of IL10 imply the greater control of
inflammatory diseases but can also lead to more severe
infectious conditions in which the effector response, rich in
IFN and TNFa, is important. Haplotypes of polymorphisms
in the promoter region of IL10 have been associated with
increased levels of IgE in atopic dermatitis (31) and celiac
disease (32). The interpretation of our haplotype analysis of
polymorphisms in the IL10 gene is difficult due the number
of analyzed individuals. Nevertheless, the power results
showed that our sample size was adequate to analyze the
IL10 -1092 A/G results individually. Of note, greater
knowledge of the production of IL10 was linked to different
haplotypes as biological relevant changes in the promoter
region that usually alter the anchoring of different tran-
scription factors, leading to differences in gene transcrip-
tion.
In summary, our data have shown that the IL10 gene is
associated with the persistent form of CMA in this
population of Brazilian children. Further studies, including
a study of blood cytokine levels, must be performed to
confirm the functional role of these cytokines in CMA.
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& APPENDIX
Supplementary Table 1 - Genotype frequency of TGFb1 -509T/C, IL10 -3575A/T, IL10 -2849 A/G, IL10 -2763 C/A and IL10 -
592A/C, comparing children with cow’s milk allergy with healthy individuals and comparing the tolerant form with the
persistent form in CMA patients.
CMA
HC CMA 2 p-value Tolerant Persistent 2 p-value
TFGB1-509
CC 36 (0.38) 17(0.34) 2 (0.14) 15 (0.42) 6.06 0.0484
CT 39 (0.41) 19 (030) 0.89 0.6419 9 (0.64) 10 (0.27)
TT 20 (0.21) 14 (0.38) 3 (0.33) 11 (0.31)
TOTAL 95 50 14 36
IL10 -3575
AA 13 (0.06) 5 (0.22) 2 (0.14) 3 (0.09) 0.47 0.7906
AT 77 (0.35) 20 (0.28) 2.83 0.2428 5 (0.36) 15 (0.44)
TT 134 (0.60) 23 (0.50) 7 (0.50) 16 (0.47)
TOTAL 224 49 14 34
IL10-2849
AA 12 (0.05) 1 (0.02) 1 (0.07) 0 (0.00) 4.52 0.1045
AG 52 (0.23) 19 (0.39) 5.54 0.0626 3 (0.21) 16 (0.46)
GG 160 (0.71) 29 (0.59) 10 (0.71) 19 (0.54)
TOTAL 224 49 14 35
IL10-2763
AA 21 (0.09) 3 (0.06) 1 (0.07) 2 (0.06) 0.40 0.8188
AC 66 (0.29) 22 (0.44) 4.16 0.1251 7 (0.50) 15 (0.42)
CC 138 (0.62) 25 (0.50) 6 (0.43) 19 (0.52)
TOTAL 224 50 14 36
IL10-592
AA 32 (0.14) 7 (0.15) 2 (0.18) 5 (0.14) 1.02 0.5944
AC 95 (0.42) 24 (0.51) 1.33 0.5154 8 (0.62) 16 (0.44)
CC 97 (0.43) 16 (0.34) 3 (0.23) 13 (0.36)
TOTAL 224 47 13 36
HC = healthy control; CMA = cow’s milk allergy; 2 = Chi-square.
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